Based on these facts, the activation of PPARα signaling and FAM in the kidney is presumed to suppress renal fibrosis and the progression of renal dysfunction in patients with chronic kidney disease (CKD) [6]. The gene discussed is PPARA; the disease is chronic kidney disease.